Recent Advances in Pancreatic Surgery for Pancreatic Ductal Adenocarcinoma (2nd Edition)
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 31 January 2026 | Viewed by 39
Special Issue Editor
2. Matsusaka City Hospital, Matsusaka-shi 515-8544, Mie, Japan
Interests: pancreatic cancer; surgical treatment; chemoradiotherapy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
With recent advances in neoadjuvant and adjuvant treatment modalities for pancreatic ductal carcinoma (PDAC), the outcomes of pancreatic surgery have improved. Additionally, notable progress has been made in surgical techniques after neoadjuvant therapy, such as the aggressive combined resection of major vessels, arterial divestment, and the introduction of laparoscopic or robotic surgery.
The focus of this Special Issue is on the following research aspects of PDAC (original or review articles): (a) resectability classification, (b) PDAC management according to the resectability classification, (c) the indication of conversion surgery and its outcome, (d) novel surgical techniques used for the combined resection of portal veins and major arteries, and (e) the indication of laparoscopic and robotic surgeries.
Dr. Shuji Isaji
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neoadjuvant therapy
- adjuvant therapy
- resectability
- conversion surgery
- surgical technique
- laparoscopic surgery
- robotic surgery
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
